Nutriband Inc.

Healthcare · Biotechnology · United States

Last price 6.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 80.71M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.